Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
- PMID: 37118032
- PMCID: PMC10427523
- DOI: 10.1007/s00198-023-06749-z
Reducing diagnostic delay in hypophosphatasia: a case series of 14 patients presenting to general rheumatology
Abstract
Objectives: Hypophosphatasia (HPP) is a rare genetic metabolic bone disease that can cause chronic pain and fractures. Its hallmark is a persistently low serum ALP. HPP is now recognised by many osteoporosis specialists, but other specialists, such as rheumatologists and primary care physicians, may be less aware of this condition, causing diagnostic delay and possible harm to these patients. Our objective was to highlight features that can reduce this delay.
Methods: We retrospectively analysed 14 patients that presented with musculoskeletal pain to general rheumatology clinic at St. George's Hospital and were subsequently diagnosed with HPP.
Results: Median diagnostic delay was 13 years. All patients had an ALP below reference range for age and gender, with lowest mean ALP of 16 IU/L. All but one patient were women with median age of 51 years. Most common presentation was peripheral joint pain in 85.7% of patients. This was due to early-onset CPPD (calcium pyrophosphate deposition disease) in 71.4% of patients, osteoarthritis in 50%, or bursitis in 50%. Axial pain was reported in 64% of patients due to osteoarthritis or spinal stenosis. Fifty percent of patients had a history of long bone pain. Fifty percent had previous fracture(s). A total of 28.6% of patients had psoriatic arthritis, of which 1 patient had spondyloarthropathy, and 4 patients also had enthesitis.
Conclusion: Patients with HPP can present to rheumatology with musculoskeletal pain, and if a persistently low ALP is confirmed, this may reduce the diagnostic delay of this rare disease. Similar to other rheumatologic patients, musculoskeletal pain in HPP was noted in peripheral joints and in the spine with almost a third of patients having psoriatic arthritis. Pain was also noted in the long bones, a feature consistent with metabolic bone disease. The diagnosis of HPP was also more likely in those patients with a personal or family history of dental disease or arthritis.
Keywords: Alkaline phosphatase; Hypophosphatasia; Musculoskeletal pain.
© 2023. The Author(s).
Conflict of interest statement
None.
Similar articles
-
Identifying adult hypophosphatasia in the rheumatology unit.Orphanet J Rare Dis. 2022 Dec 14;17(1):435. doi: 10.1186/s13023-022-02572-7. Orphanet J Rare Dis. 2022. PMID: 36514157 Free PMC article.
-
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients.Osteoporos Int. 2023 Feb;34(2):327-337. doi: 10.1007/s00198-022-06597-3. Epub 2022 Nov 24. Osteoporos Int. 2023. PMID: 36434431
-
Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry.BMC Musculoskelet Disord. 2019 Feb 14;20(1):80. doi: 10.1186/s12891-019-2420-8. BMC Musculoskelet Disord. 2019. PMID: 30764793 Free PMC article.
-
Proposing a clinical algorithm for better diagnosis of hypophosphatasia in resource-limiting situations.Osteoporos Int. 2022 Dec;33(12):2479-2493. doi: 10.1007/s00198-022-06480-1. Epub 2022 Jul 1. Osteoporos Int. 2022. PMID: 35776147 Review.
-
ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.Endocr Pract. 2016 Aug;22(8):941-50. doi: 10.4158/EP15890.OR. Epub 2016 Apr 4. Endocr Pract. 2016. PMID: 27042741 Review.
Cited by
-
Disease burden by ALPL variant number in patients with non-life-threatening hypophosphatasia in the Global HPP Registry.J Med Genet. 2025 Mar 20;62(4):249-257. doi: 10.1136/jmg-2024-110383. J Med Genet. 2025. PMID: 39965917 Free PMC article.
-
Case series demonstrating the effectiveness of Zn supplements in adults with hypophosphatasia who were overlooked for a long time.SAGE Open Med Case Rep. 2025 Jul 23;13:2050313X251360163. doi: 10.1177/2050313X251360163. eCollection 2025. SAGE Open Med Case Rep. 2025. PMID: 40717836 Free PMC article.
-
Mobility and Quality of Life in Adults with Paediatric-Onset Hypophosphatasia Treated with Asfotase Alfa: Results from UK Managed Access Agreement.Adv Ther. 2025 May;42(5):2429-2444. doi: 10.1007/s12325-025-03168-w. Epub 2025 Mar 26. Adv Ther. 2025. PMID: 40138164 Free PMC article.
-
Whole genome sequencing in adults with clinical hallmarks of hypophosphatasia negative for ALPL variants.Mol Biol Rep. 2024 Sep 14;51(1):984. doi: 10.1007/s11033-024-09906-7. Mol Biol Rep. 2024. PMID: 39276275 Free PMC article.
-
High Prevalence of Nephrocalcinosis in Hypophosphatasia Patients with the ALPL c.1559del Gene Variant.JMA J. 2025 Jan 15;8(1):204-208. doi: 10.31662/jmaj.2024-0138. Epub 2024 Dec 20. JMA J. 2025. PMID: 39926094 Free PMC article.
References
-
- Kaur J, Nourabadi S, Chavez L, Sachemchi I. A concise review on hypophosphatasia with case report. Int J Med. 2016;4(2):39. doi: 10.14419/ijm.v4i2.6397. - DOI
-
- Högler W, Langman C, Gomes Da Silva H, Fang S, Linglart A, Ozono K, et al. Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry. BMC Musculoskelet Disord. 2019;20(1):1–9. doi: 10.1186/s12891-019-2420-8. - DOI - PMC - PubMed
-
- Berkseth KE, Tebben PJ, Drake MT, Hefferan TE, Jewison DE, Wermers RA (2013) Clinical spectrum of hypophosphatasia diagnosed in adults. Bone 54(1):217. 10.1016/j.bone.2013.01.024 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical